{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-24T12:24:53.573402+00:00",
  "news": [
    {
      "title": "AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQcWpiRG9leU85RUVNSFpKeE5kQ1FrTlRCcnc1V3lqM05nbGdtLTREUUNPUlRmZVZQQVFlXzI1b2VPN2Z1bTlCdlN6UUxhN3YwanhaZTdHQ2lXNEtfdVJXdTVJM1ZPUXVDeENVV1NjbnhlbHVDMnpjQzMweFVsNmk5U2diRV8zbGpBdGZQRzk0eHp3SmFHOXhhZTZkQXlnMDdkd1FPa1JwN1ZFVlZrb1Y1UGdLOURHZy1wVmFmQWZ5clFRUnJIT0F2MGlFb2NNdDZKYlBfdmM3ZVBubGdmOGwyYUNxV3o?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQcWpiRG9leU85RUVNSFpKeE5kQ1FrTlRCcnc1V3lqM05nbGdtLTREUUNPUlRmZVZQQVFlXzI1b2VPN2Z1bTlCdlN6UUxhN3YwanhaZTdHQ2lXNEtfdVJXdTVJM1ZPUXVDeENVV1NjbnhlbHVDMnpjQzMweFVsNmk5U2diRV8zbGpBdGZQRzk0eHp3SmFHOXhhZTZkQXlnMDdkd1FPa1JwN1ZFVlZrb1Y1UGdLOURHZy1wVmFmQWZ5clFRUnJIT0F2MGlFb2NNdDZKYlBfdmM3ZVBubGdmOGwyYUNxV3o?oc=5\" target=\"_blank\">AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-12-19T19:23:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Our Workforce - Amgen",
      "link": "https://news.google.com/rss/articles/CBMidEFVX3lxTE1XUlJNRkVUcUpIektWMk1uMWF0UFlKZzNHM0o0b0NiTE5BN3VhcDBrMmRWdFRKS09ZdnFyem4zMXhOOWE5RUZEcElzcGFKVG5XMFJscFRmQW5iemtVYXZFNWtuUFRwX1AxdC10dVd2bXIwY2JD?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMidEFVX3lxTE1XUlJNRkVUcUpIektWMk1uMWF0UFlKZzNHM0o0b0NiTE5BN3VhcDBrMmRWdFRKS09ZdnFyem4zMXhOOWE5RUZEcElzcGFKVG5XMFJscFRmQW5iemtVYXZFNWtuUFRwX1AxdC10dVd2bXIwY2JD?oc=5\" target=\"_blank\">Our Workforce</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-22T20:35:28+00:00",
      "source": "Amgen"
    },
    {
      "title": "Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - Zacks Investment Research",
      "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQai1uOGMxWTYzekhQUVZRTDVxY0d3ajFUZzV0d3FtaDFDTWh6SFNzQUp6XzI5MVg3Y0RXc1dneFI1T0RLamxnLXJmMEZMVk5LbG53eVlHRHVoY3IydUx2a2dzV1lIcDNyWmRvTVJKSENwOXd0WWE3eDhMMUFobEZnTmc2bm9ENWdnTlNjQjJIN2h4Q3NrQndKNnphSDNjZHlzVGo2RkxKbnNHdXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQai1uOGMxWTYzekhQUVZRTDVxY0d3ajFUZzV0d3FtaDFDTWh6SFNzQUp6XzI5MVg3Y0RXc1dneFI1T0RLamxnLXJmMEZMVk5LbG53eVlHRHVoY3IydUx2a2dzV1lIcDNyWmRvTVJKSENwOXd0WWE3eDhMMUFobEZnTmc2bm9ENWdnTlNjQjJIN2h4Q3NrQndKNnphSDNjZHlzVGo2RkxKbnNHdXc?oc=5\" target=\"_blank\">Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Zacks Investment Research</font>",
      "published": "2025-12-23T14:33:06+00:00",
      "source": "Zacks Investment Research"
    },
    {
      "title": "Has Amgen’s 26% Rally in 2025 Already Priced In Its Obesity and Oncology Ambitions? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMifkFVX3lxTFAtWlJQaXIzam92NTc4WHBtS2lhcXRWZUpHWVc2ZHB3QjhIME5BQnJ3ZUhCZDRrb2JhT3A5cF9ObDFuN3htS2syQjZabGpyRWpVel9rdkdiZnRJS3VkQjJfS0h0Y3R5OWcyejJkZEtfMGJ2N0txZVVEVmo1d3F2Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifkFVX3lxTFAtWlJQaXIzam92NTc4WHBtS2lhcXRWZUpHWVc2ZHB3QjhIME5BQnJ3ZUhCZDRrb2JhT3A5cF9ObDFuN3htS2syQjZabGpyRWpVel9rdkdiZnRJS3VkQjJfS0h0Y3R5OWcyejJkZEtfMGJ2N0txZVVEVmo1d3F2Zw?oc=5\" target=\"_blank\">Has Amgen’s 26% Rally in 2025 Already Priced In Its Obesity and Oncology Ambitions?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-20T05:12:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Trump Inks Reduced Drug Pricing Deal With Nine Pharmaceutical Giants - Forbes",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQcXdKT0hqWG9RTFlQTGlCeHB3NERCWER3b19tcWxYeFZEOWRpZW5XNnduRXVvdmpxbURnRnpxR09SUkhlLWZ3VnNxMTVFRzVDSGZsMkdrZk1WOFF0SzhwdHF6SE11LW9vQng5bHoxNXRZajdlSFhPWm4zT2NFT1dRbjhjNVVPN0ZqMmpJQUdLd2JvaTNKV1QweWdaSUNENm95SmNwMEhKOGU1Um5UcmRxaUVMNm96N0V6Mk5jc2tseVJ0Z1VJOVRWZG9taE95YUFzUHdYQlo5SQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQcXdKT0hqWG9RTFlQTGlCeHB3NERCWER3b19tcWxYeFZEOWRpZW5XNnduRXVvdmpxbURnRnpxR09SUkhlLWZ3VnNxMTVFRzVDSGZsMkdrZk1WOFF0SzhwdHF6SE11LW9vQng5bHoxNXRZajdlSFhPWm4zT2NFT1dRbjhjNVVPN0ZqMmpJQUdLd2JvaTNKV1QweWdaSUNENm95SmNwMEhKOGU1Um5UcmRxaUVMNm96N0V6Mk5jc2tseVJ0Z1VJOVRWZG9taE95YUFzUHdYQlo5SQ?oc=5\" target=\"_blank\">Trump Inks Reduced Drug Pricing Deal With Nine Pharmaceutical Giants</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Forbes</font>",
      "published": "2025-12-19T20:23:32+00:00",
      "source": "Forbes"
    },
    {
      "title": "Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQdWZiNEhERE82OGhtUnM0R29TTkVMZVJ3RnlzNm1FbHpFa3ZSSkFzTzUwRkctd1BUSVN2ZkNNT1VzRkFMZExRRnhlSE1mN1ZIU0lzRm95VjRTYTItX29rZ1ROcElHQ05nWEEyc1FvS29oQTExMEZwUWp4eEw0dlhRZ1lJYkZyWmVVRDR2bEVKT3lCZ290RmRPSnlSZHpFNjJ1NzNrWEhESlVtTXpuQm1kTmZwUWpuelRDTWZNclhVenlZSUE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQdWZiNEhERE82OGhtUnM0R29TTkVMZVJ3RnlzNm1FbHpFa3ZSSkFzTzUwRkctd1BUSVN2ZkNNT1VzRkFMZExRRnhlSE1mN1ZIU0lzRm95VjRTYTItX29rZ1ROcElHQ05nWEEyc1FvS29oQTExMEZwUWp4eEw0dlhRZ1lJYkZyWmVVRDR2bEVKT3lCZ290RmRPSnlSZHpFNjJ1NzNrWEhESlVtTXpuQm1kTmZwUWpuelRDTWZNclhVenlZSUE?oc=5\" target=\"_blank\">Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-23T13:05:39+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5\" target=\"_blank\">Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-12T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen takes action with U.S. government to lower medicine costs - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNMVBpSG9aX1M0WUhsOXJoMWlnU3l0MlZVQ2RZQXctTjdDbHZ5X3c4TnZhNld2aG5WUkM1dWRiRWNkZ2JYSWMtaEl1Z1JuWTdySTBnXzNFMk50R2xzblowQ1M1ci04M0IzU2dvXzdjbS00NkZXTE4ybndwSHZDcDJ1eTg2MHVyWG1yT1RhZVVDU1hfTzVjbm1NaHRoNUgtaGE4SkVwdWpuQTFraWs3OVFWUE15dEYyRXNRV1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxNMVBpSG9aX1M0WUhsOXJoMWlnU3l0MlZVQ2RZQXctTjdDbHZ5X3c4TnZhNld2aG5WUkM1dWRiRWNkZ2JYSWMtaEl1Z1JuWTdySTBnXzNFMk50R2xzblowQ1M1ci04M0IzU2dvXzdjbS00NkZXTE4ybndwSHZDcDJ1eTg2MHVyWG1yT1RhZVVDU1hfTzVjbm1NaHRoNUgtaGE4SkVwdWpuQTFraWs3OVFWUE15dEYyRXNRV1E?oc=5\" target=\"_blank\">Amgen takes action with U.S. government to lower medicine costs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-12-19T20:09:14+00:00",
      "source": "Investing.com"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-23",
      "close": 331.489990234375
    },
    "history": [
      {
        "date": "2025-12-15",
        "close": 325.30999755859375
      },
      {
        "date": "2025-12-16",
        "close": 326.739990234375
      },
      {
        "date": "2025-12-17",
        "close": 326.010009765625
      },
      {
        "date": "2025-12-18",
        "close": 324.4200134277344
      },
      {
        "date": "2025-12-19",
        "close": 327.3800048828125
      },
      {
        "date": "2025-12-22",
        "close": 331.3900146484375
      },
      {
        "date": "2025-12-23",
        "close": 331.489990234375
      }
    ],
    "name": "Amgen Inc."
  }
}